Genomic Biomarkers for Pharmaceutical Development: Advancing Personalized Health Care provides an in-depth review of the state of translational science across a

Although we have seen increased spending on drug research and development, the submission of new drug applications to the US Food and Drug Administration (FDA)

This book continues the legacy of a well-established reference within the pharmaceutical industry – providing perspective, covering recent developments in tec

Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition an

This chapter presents the processes required for the translation of a biomarker discovery from the research laboratory into a validated diagnostic for clinical